Applied Therapeutics, Inc.
APLT
$0.4101
-$0.0309-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.89% | 109.80% | -728.04% | -161.13% | -121.82% |
| Total Depreciation and Amortization | -11.86% | 5.17% | 5.26% | -94.74% | 6.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.54% | -237.78% | 2,854.99% | 1,293.52% | 741.59% |
| Change in Net Operating Assets | 261.06% | -130.56% | -242.48% | 15,381.82% | 52.35% |
| Cash from Operations | -58.43% | -37.34% | -170.54% | -7.00% | 24.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -100.00% |
| Cash from Investing | -- | -- | -- | 100.00% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 50.00% | 50.16% | 50.11% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -105.80% | 18,668.65% | 3,256.06% | 1,806.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,367.25% | -291.25% | 1,442.91% | 152.43% | 112.00% |
